Blood cancers

Waldenström macroglobulinaemia guidelines highlight lack of treatment options in Australia

Australia’s first guidelines for the treatment of Waldenström macroglobulinaemia (WM) highlights that Australia still trails behind other countries when it comes to being able to offer the newer targeted therapies for the condition. Clinical haematologist, Associate Professor Dipti Talaulikar, from the Myeloma Australia Medical and Scientific Advisory Group who helped develop the guidelines, said while ...

Already a member?

Login to keep reading.

© 2021 the limbic